{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T08:01:43Z","timestamp":1790928103186,"version":"4.1.0"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1097\/dad.0000000000001822","type":"journal-article","created":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T05:00:14Z","timestamp":1606885214000},"page":"394-395","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Pityriasis Rubra Pilaris-Like Reaction Induced by a Tyrosine Kinase Inhibitor, the Ponatinib"],"prefix":"10.1097","volume":"43","author":[{"given":"Margaux","family":"Mongereau","sequence":"first","affiliation":[{"name":"Dermatology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Hillion","sequence":"additional","affiliation":[{"name":"Dermatology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loic","family":"Fouillard","sequence":"additional","affiliation":[{"name":"Hematology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Francois","family":"Boivin","sequence":"additional","affiliation":[{"name":"Pathology, Grand H\u00f4pital de l'Est Francilien\u2014Site de Marne-la-Vall\u00e9e, Jossigny, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Gaudron","sequence":"additional","affiliation":[{"name":"Dermatology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,12,1]]},"reference":[{"key":"R1-20250616","first-page":"931","article-title":"Pityriasis rubra pilaris","volume":"128","author":"Griffiths","year":"2001","journal-title":"Ann Dermatol Venereol."},{"key":"R2-20250616","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1529-8019.2011.01431.x","article-title":"Adverse cutaneous reactions secondary to tyrosine kinase inhibitors including imatinib mesylate, nilotinib, and dasatinib","volume":"24","author":"Amitay-Laish","year":"2011","journal-title":"Dermatol Ther."},{"key":"R3-20250616","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1684\/ejd.2015.2684","article-title":"Cutaneous adverse reactions of imatinib therapy in patients with chronic myeloid leukemia: a six-year follow up","volume":"26","author":"Dervis","year":"2016","journal-title":"Eur J Dermatol."},{"key":"R4-20250616","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1158\/1535-7163.MCT-10-1044","article-title":"Potent activity of ponatinib (AP24534) in models of FLT3-driven acute myeloid leukemia and other hematologic malignancies","volume":"10","author":"Gozgit","year":"2011","journal-title":"Mol Cancer Ther."},{"key":"R5-20250616","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1056\/NEJMoa1205127","article-title":"Ponatinib in refractory Philadelphia chromosome-positive leukemias","volume":"367","author":"Cortes","year":"2012","journal-title":"N Engl J Med."},{"key":"R6-20250616","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s40800-017-0055-y","article-title":"Ichthyosiform pityriasis rubra pilaris-like eruption secondary to ponatinib therapy: case report and literature review","volume":"4","author":"Eber","year":"2017","journal-title":"Drug Saf Case Rep."},{"key":"R7-20250616","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.annder.2018.04.009","article-title":"A new case of pityriasis rubra pilaris-like eruption associated with ponatinib, a tyrosine kinase inhibitor","volume":"145","author":"Krygier","year":"2018","journal-title":"Ann Dermatol Venereol."},{"key":"R8-20250616","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1016\/j.jaad.2013.04.061","article-title":"Pityriasis rubra pilaris-like eruption associated with the multikinase inhibitor ponatinib","volume":"69","author":"Jack","year":"2013","journal-title":"J Am Acad Dermatol."},{"key":"R9-20250616","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/bjd.13692","article-title":"Ponatinib-induced pityriasiform, folliculocentric and ichthyosiform cutaneous toxicities","volume":"173","author":"Alloo","year":"2015","journal-title":"Br J Dermatol."},{"key":"R10-20250616","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.jaad.2010.03.015","article-title":"Sorafenib-induced eruption resembling pityriasis rubra pilaris","volume":"65","author":"Paz","year":"2011","journal-title":"J Am Acad Dermatol."},{"key":"R11-20250616","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/ced.12081","article-title":"Pityriasis rubra pilaris-like reaction induced by imatinib","volume":"38","author":"Plana","year":"2013","journal-title":"Clin Exp Dermatol."}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000001822","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T15:05:58Z","timestamp":1750086358000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000001822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,1]]},"references-count":11,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000001822","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.740599634.793587723","asserted-by":"object"}]},"ISSN":["0193-1091"],"issn-type":[{"value":"0193-1091","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,1]]}}}